The United States Patent and Trademark Office (USPTO) today announced a new COVID-19 prioritized examination program for certain trademark and service mark applications.Under this new program, the USPTO will accept petitions to advance the initial examination of applications for marks used to identify qualifying COVID-19 medical products and services. Additionally, the USPTO will waive the fee for such petitions.
USPTOで優先的に審査される出願は、COVID-19の予防および/または治療に使用される米国食品医薬品局(FDA)の承認の対象となる製品、或いはCOVID-19の予防および/または治療のための医学的または医学的調査の役務を対象とする必要があります。